http://aofcare.com/WordPress Nursing Research and Legal Nurse Consulting Expertise to Legal Profession Fri, 03 Sep 2010 12:06:20 +0000 http://backend.userland.com/rss092 en Ezetimibe/Simvastatin (marketed as Vytorin) Simvastatin (marketed as Zocor) Ezetimibe (marketed as Zetia) Audience: Endocrinologists, cardiologists, other healthcare professionals, patients [Posted 08/21/2008] FDA informed healthcare professionals that the Agency is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a possible association between the use of Vytorin and a ... http://aofcare.com/WordPress/?p=29  "Byetta (Exenatide) and Postmarketing Reports of Acute Pancreatitis"BETHESDA, MD -- October 16, 2007 -- U.S. Food and Drug Administration (FDA) has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), a drug used to treat adults with type 2 diabetes. An association between Byetta and acute pancreatitis ... http://aofcare.com/WordPress/?p=28 function getSharePasskey() { return 'ex=1350360000&en=8737489b009f929b&ei=5124';} function getShareURL() { return encodeURIComponent('http://www.nytimes.com/2007/10/17/health/17infect.html'); } function getShareHeadline() { return encodeURIComponent('Deadly Bacteria Found to Be More Common'); } function getShareDescription() { return encodeURIComponent('A study suggests that a virulent drug-resistant bacterium spreading in hospitals and nursing homes may be twice as common as once ... http://aofcare.com/WordPress/?p=27           APPoisoned toothpaste from China was distributed more widely in the U.S. than originally reported. (June 28) - After federal health officials discovered last month that tainted Chinese toothpaste had entered the United States, they warned that it would most likely be found in discount stores.   In fact, the toothpaste has been distributed ... http://aofcare.com/WordPress/?p=21 (Update2) By Justin Blum and Michelle Fay Cortez   GlaxoSmithKline's Avandia pills on display July 30 (Bloomberg) -- GlaxoSmithKline Plc's diabetes pill Avandia should be removed from the market because of heart risks, a U.S. drug safety scientist said.There is ``no evidence of major clinical health benefits'' from Avandia and leaving it on ... http://aofcare.com/WordPress/?p=23 Posted : Mon, 18 Jun 2007 16:56:00 GMTAuthor : The Lanier Law Firm Category : PressRelease News Alerts by Email click here ) Create your own RSS PressRelease News | Create your own RSS | Home ATLANTIC CITY, N.J., June 18 /PRNewswire/ -- New Jersey Superior Court judge Carol E. ... http://aofcare.com/WordPress/?p=20 DGNews OTTAWA, CANADA -- June 12, 2007 -- Hoffmann-La Roche Limited, in consultation with Health Canada, would like to inform health professionals of important new safety information regarding the use of Avastin (bevacizumab). Avastin is a recombinant humanized monoclonal antibody that is directed against the vascular endothelial growth factor (VEGF). It is ... http://aofcare.com/WordPress/?p=19   ABSTRACTBackground Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined. Methods We conducted searches of the published literature, the Web site of the Food and Drug Administration, and a clinical-trials registry maintained by the drug ... http://aofcare.com/WordPress/?p=17 FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA FDA News FOR IMMEDIATE RELEASE P07-69 April 17, 2007    Media Inquiries: Heidi Rebello, 301-827-6242 Consumer Inquiries: 888-INFO-FDA U.S. Food and Drug Administration (FDA) investigators and U.S. Marshals today seized all implantable medical devices from Shelhigh, Inc., Union, N.J., after finding significant deficiencies in the company's ... http://aofcare.com/WordPress/?p=16 Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) Recent reports of studies with erythropoiesis-stimulating agents (ESAs) have shown a higher chance of serious and life-threatening side effects and greater number of deaths in patients treated with these agents.  ESAs stimulate the bone marrow to make more red blood ... http://aofcare.com/WordPress/?p=13 Assurance of Care Legal Nurse Consultants › Create New Post — WordPress http://aofcare.com/WordPress/?p=12 TEQUINBMS notified FDA and healthcare professionals about proposed changes to the prescribing information for Tequin, including an updating of the existing WARNING on hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar), and a CONTRAINDICATION for use in diabetic patients. The changes also include information identifying other risk factors for developing low blood sugar and ... http://aofcare.com/WordPress/?p=11 KETEK ALERTThe Food and Drug Administration notified healthcare professionals and patients that it completed its safety assessment of Ketek (telithromycin), indicated for the treatment of acute exacerbation of chronic bronchitis, acute bacterial sinusitis and community acquired pneumonia of mild to moderate severity, including pneumonia caused by resistant strep infections. The drug has been associated with ... http://aofcare.com/WordPress/?p=10 New Warning for Attention Deficit Drugs AP WASHINGTON (Feb. 21) - Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart problems, including sudden death. Karen Elshout, St. Louis Post-Dispatch / MCTA patient takes part in a study on attention ... http://aofcare.com/WordPress/?p=9 FDA: Zelnorm Being Pulled From MarketROCKVILLE, MD -- March 30, 2007 -- FDA is issuing this public health advisory to inform patients and health care professionals that the sponsor of Zelnorm (tegaserod maleate), Novartis Pharmaceuticals Corporation, has agreed to stop selling Zelnorm. Zelnorm is being taken off the market because ... http://aofcare.com/WordPress/?p=7 AP WASHINGTON (March 9) - Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.    Warnings on Three Drugs Talk About It: Post Thoughts   At issue are drugs ... http://aofcare.com/WordPress/?p=6 Tablets ACTOplus met (pioglitazone and metformin hydrochloride) Tablets Duetact (pioglitazone and glimepiride) Tablets Audience: Endocrinologists, other healthcare professionals, consumers [Posted 03/09/2007] Takeda and FDA notified healthcare professionals of recent safety data concerning pioglitazone-containing products. The results of an analysis of the manufacturer's clinical trial database of pioglitazone taking pioglitazone than those taking a ... http://aofcare.com/WordPress/?p=5 AP WASHINGTON (Feb. 21) - Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart problems, including sudden death           Karen Elshout, St. Louis Post-Dispatch / MCT A patient takes part in a study on attention deficit hyperactivity disorder. The ... http://aofcare.com/WordPress/?p=4   http://aofcare.com/WordPress/?p=3 Welcome to Assurance of Care.  Please utilize our excellent database of medical-legal links.  If you have a specific topic you would like for us to provide you with evidenced based practice information, please let us know.Thanks,Assurance of Care http://aofcare.com/WordPress/?p=1